Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2007 Mar;93(3):403-8.
doi: 10.1136/hrt.2005.085761.

Management of patients with non-ischaemic cardiomyopathy

Audrey H Wu  1
Affiliations
Review

Management of patients with non-ischaemic cardiomyopathy

Audrey H Wu. Heart. 2007 Mar.
No abstract available

PubMed Disclaimer

Conflict of interest statement

In compliance with EBAC/EACCME guidelines, all authors participating in Education in Heart have disclosed potential conflicts of interest that might cause a bias in the article. Dr Wu has no potential conflicts of interest to declare.

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Follath F. Nonischemic heart failure: epidemiology, pathophysiology, and progression of disease. J Cardiovasc Pharmacol 199933(Suppl 3)S31–S35. - PubMed
    1. Aaronson K D, Schwartz J S, Chen T M.et al Development and prospective validation of a clinical index to predict survival in ambulatory patients referred for cardiac transplant evaluation. Circulation 1997952660–2667. - PubMed
    1. Xie G Y, Berk M R, Smith M D.et al Prognostic value of Doppler transmitral flow patterns in patients with congestive heart failure. J Am Coll Cardiol 199424132–139. - PubMed
    1. Kasper E K, Agema W R, Hutchins G M.et al The causes of dilated cardiomyopathy: a clinicopathologic review of 673 consecutive patients. J Am Coll Cardiol 199423586–590. - PubMed
    1. Packer M, Poole‐Wilson P A, Armstrong P W.et al Comparative effects of low and high doses of the angiotensin‐converting enzyme inhibitor, lisinopril, on morbidity and mortality in chronic heart failure. ATLAS Study Group. Circulation 19991002312–2318. - PubMed

Substances